Endoscopy 2025; 57(S 02): S198-S199
DOI: 10.1055/s-0045-1805493
Abstracts | ESGE Days 2025
Moderated poster
EUS guided biliary drainage 03/04/2025, 12:00 – 13:00 Poster Dome 2 (P0)

Endoscopic Ultrasound (EUS)-Guided Gallbladder Drainage vs EUS-Guided Bile Duct Drainage After Failed ERCP for Malignant Biliary Obstruction: An International Multicenter Study

Authors

  • M Benedetto

    1   Humanitas Mater Domini, Castellanza, Italy
  • D Paduano

    1   Humanitas Mater Domini, Castellanza, Italy
  • D Ramai

    2   Gastroenterology and Hepatology, University of Utah Health, Salt Lake City, United States of America
  • G franchellucci

    3   Humanitas Research Hospital,Department of Gastroenterology and Hepatology, Rozzano, Italy
  • C Barbera

    4   Gastroenterologia ed Endoscopia – Ospedale Teramo, Teramo, Italy
  • A Fugazza

    5   Humanitas Research Hospital,Department of Gastroenterology and Hepatology, Rozzano, Italy, Rozzano, Italy
  • G Vanella

    6   IRCCS San Raffaele Scientific Institute, Milan, Italy
  • F Frigo

    7   Ospedale San Giovanni Bosco, Torino, Italy
  • P Arcidiacono

    8   Vita-Salute San Raffaele University, Milano, Italy
  • G De Nucci

    9   Garbagnate Milanese Hospital, Milan, Italy
  • A Anderloni

    10   Fondazione I.R.C.C.S. Policlinico San Matteo, Gastroenterology and Digestive Endoscopy Unit, Pavia, Italy
  • A Larghi

    11   Agostino Gemelli University Policlinic, Rome, Italy
  • S F Crinò

    12   University of Verona, Via San Francesco, Verona, VR, Italy, Italy
  • S Sundaram

    13   TATA MEMORIAL HOSPITAL, Parel, Mumbai, Mumbai, India
  • E Troncone

    14   Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
  • KD C Pham

    15   Haukeland University Hospital / Health Bergen, Bergen, Norway
  • A Al-Lehibi

    16   King Saud Bin Abduaziz University-Health Science, King Fahad Medical City, Riyadh, Saudi Arabia
  • E Forti

    17   Digestive Endoscopy Unit, Ospedale Niguarda, Milano, Italy
  • C Gentile

    1   Humanitas Mater Domini, Castellanza, Italy
  • G Aragona

    18   Gastroenterology and Hepatology Unit, Guglielmo da Saliceto Hospital, Piacenza, Italy
  • G Manes

    19   Gastroenterology Unit, Rho-Garbagnate Hospital, ASST Rhodense, Milan, Italy
  • C Ko

    20   Health University Of Utah, Salt Lake City, United States of America
  • D M Francesco

    21   Campus biomedico University Hospital, Roma, Italy
  • F Auriemma

    1   Humanitas Mater Domini, Castellanza, Italy
  • F Minini

    22   Gastroenterology and Digestive Endoscopy Unit, Humanitas Research Hospital, Rozzano, Italy
  • M Fiacca

    23   Humanitas Research Hospital, Milan, Italy
  • C Federica

    24   Humanitas ma, castellanza, Italy
  • L L De

    25   Endoscopic Unit, ASST Santi Paolo e Carlo, Milan, Italy
  • A Y Teoh

    26   Prince of Wales Hospital, Hong Kong, Hong Kong
  • C Gallo

    27   ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
  • M Mutignani

    28   ASST Great Metropolitan Niguarda, Milano, Italy
  • M Santi

    29   Azienda Ospedaliero – Universitaria di Modena, Modena, Italy
  • H Bertani

    30   Azienda Ospedaliero-Universitaria di Modena, Modena, Italy
  • G Del Vecchio Blanco

    14   Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
  • V G Mirante

    31   AUSL Reggio Emilia, Reggio Emilia, Italy
  • E Aljahdli

    32   King Abdulaziz University Hospital, Jeddah, Saudi Arabia
  • A Alfadda

    33   Riyadh, Riyadh, Saudi Arabia
  • F Decembrino

    34   Ente Ecclesiastico-Ospedale Generale Regionale, bar, Italy
  • F Antonio

    35   Università degli studi di Foggia, Foggia, Italy
  • M Bronswijk

    36   Imeldaziekenhuis, Bonheiden, Belgium
  • S Van der Merwe

    37   University Hospital Gasthuisberg, Leuven, Belgium
  • G Fierro

    38   Rho Hospital, Rho, Italy
  • G Manes

    38   Rho Hospital, Rho, Italy
  • J D Morris

    20   Health University Of Utah, Salt Lake City, United States of America
  • B Martínez

    39   Hospital General Universitario, alican, Spain
  • S Stigliano

    40   Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy
  • J R Aparicio

    41   General University Hospital of Alicante, Alacant, Spain
  • S Lakhtakia

    42   Asian Institute of Gastroenterology, Hyderabad, India
  • A Ventra

    43   Azienda Ospedaliera Grande Ospedale Metropolitano Bianchi, Reggio Calabria, Italy
  • A Repici

    44   Humanitas Research Hospital, Rozzano, Italy
  • A Facciorusso

    45   Gastroenterology Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy
 

Aims Endoscopic ultrasound (EUS)–guided gallbladder (GB) drainage and EUS-guided bile duct (BD) drainage with lumen-apposing metal stents are alternative approaches to endoscopic retrograde cholangiopancreatography (ERCP). We compared EUS-GB and EUS-BD as second line therapies in the setting of failed ERCP for malignant biliary obstruction (MBO) [1] [2] [3].

Methods This was an international multicenter retrospective observational study at 28 tertiary-care centers through August 2024. Consecutive patients with MBO who underwent EUS-GB or EUS-BD as second line therapy with LAMS placement were included. Outcomes were compared using propensity score matching. Cohorts were compared using Chi-square, Mann-Whitney tests, and logistic regression.

Results Five hundred and twenty-nine patients (254 males; average age 73±12 years) underwent EUS guided drainage where 136 patients underwent EUS GB drainage, and 393 patients underwent EUS BD drainage. Most patients developed MBO from pancreatic cancer (79%). AXIOS stents were used in most cases (91%) compared to SPAXUS (9%). Overall, technical success was reported in 96% of cases and clinical success in 87% of cases. After 1-to-1 propensity score matching, 224 patients were selected (112 per group). EUS-GB showed higher technical success compared to EUS-BD (97% vs 92%, P=0.045). However, EUS-GB showed lower clinical success compared to EUS-BD (74% vs 86%, P=0.030). No statistical differences were reported in adverse events for EUS-GB and EUS-BD including bleeding (6% vs 3%, P=0.196), perforation (0% vs 2%, P=0.155), stent occlusion (5% vs 4%, P=0.528), stent migration (2% vs 1%, P=0.561), and acute pancreatitis (2% vs 0%, P=0.155), respectively. Stent type was not associated with technical success (AXIOS 94% vs SPAXUS 94%, P=0.983) or clinical success (AXIOS 78% vs SPAXUS 88%, P=0.188). On univariate analysis, EUS-BD was not a significant predictor of technical success (P=0.059) but had higher odds of clinical success compared to EUS-GD (OR=2.10, 95% CL 1.07-4.13, P=0.032). univariate analysis.

Conclusions In patients with MBO, EUS-GB and EUS-BD are reasonable therapeutic alternatives in the setting of failed ERCP. However, EUS-BD may offer higher clinical success when compared to EUS-GB.



Publication History

Article published online:
27 March 2025

© 2025. European Society of Gastrointestinal Endoscopy. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 
  • References

  • 1 Mangiavillano B, Moon JH, Facciorusso A, Di Matteo F, Paduano D, Bulajic M, Ofosu A, Auriemma F, Lamonaca L, Yoo HW, Rea R, Massidda M, Repici A.. EUS-guided biliary drainage with a novel electrocautery-enhanced lumen apposing metal stent as first approach for distal malignant biliary obstruction: a prospective study. Endosc Int Open 2022; 10 (07): E998-E1003 PMID: 35845026; PMCID: PMC9286767.
  • 2 Paduano D, Facciorusso A, De Marco A, Ofosu A, Auriemma F, Calabrese F, Tarantino I, Franchellucci G, Lisotti A, Fusaroli P, Repici A, Mangiavillano B.. Endoscopic Ultrasound Guided Biliary Drainage in Malignant Distal Biliary Obstruction. Cancers (Basel) 2023; 15 (02): 490 PMID: 36672438; PMCID: PMC9856645.
  • 3 Facciorusso A, Mangiavillano B, Paduano D, Binda C, Crinò SF, Gkolfakis P, Ramai D, Fugazza A, Tarantino I, Lisotti A, Fusaroli P, Fabbri C, Anderloni A.. Methods for Drainage of Distal Malignant Biliary Obstruction after ERCP Failure: A Systematic Review and Network Meta-Analysis. Cancers (Basel) 2022; 14 (13): 3291 PMID: 35805062; PMCID: PMC9266204.